• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分析血清肿瘤标志物水平评估手术结果及预测预后:对甲状腺髓样癌患者验证的一种理论建议

[Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].

作者信息

Miyauchi A

机构信息

2nd Dept. of Surgery, Kagawa Medical School.

出版信息

Gan No Rinsho. 1988 May;34(6):739-43.

PMID:3379756
Abstract

A theory to evaluate the benefit of surgery and to predict the prognosis in patients with a malignant tumor by analysis of serum tumor marker levels is proposed, and an analysis of 67 patients with a medullary thyroid carcinoma is reported as an example of its application. This theory incorporates the following concepts: the tumor marker doubling time, the reduction index, the expected prolongation of survival by surgical therapy, and the expected duration of survival after surgery. These parameters allow a quantitative judgement of the surgical therapy and a quantitative prediction of the subsequent prognosis as demonstrated in patients with a medullary thyroid carcinoma.

摘要

提出了一种通过分析血清肿瘤标志物水平来评估手术益处并预测恶性肿瘤患者预后的理论,并报告了对67例甲状腺髓样癌患者的分析作为其应用实例。该理论包含以下概念:肿瘤标志物倍增时间、降低指数、手术治疗预期延长的生存期以及术后预期生存期。这些参数能够对手术治疗进行定量判断,并对后续预后进行定量预测,如在甲状腺髓样癌患者中所示。

相似文献

1
[Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].通过分析血清肿瘤标志物水平评估手术结果及预测预后:对甲状腺髓样癌患者验证的一种理论建议
Gan No Rinsho. 1988 May;34(6):739-43.
2
[Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels].[通过血清降钙素水平分析评估甲状腺髓样癌的外科治疗]
Nihon Geka Gakkai Zasshi. 1987 Jan;88(1):102-8.
3
[Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].[血清癌胚抗原倍增时间及降钙素水平在甲状腺髓样癌中的预后价值]
Gan No Rinsho. 1986 Oct;32(12):1519-24.
4
[Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].[降钙素水平在甲状腺髓样癌诊断及治疗效果评估中的分析]
Pol Tyg Lek. 1989;44(32-33):757-9.
5
[Use of tumor markers in monitoring thyroid carcinoma].[肿瘤标志物在甲状腺癌监测中的应用]
Chir Ital. 1987 Feb;39(1):87-95.
6
[Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].[甲状腺髓样癌中的血浆肿瘤标志物(降钙素和癌胚抗原)]
Bull Cancer. 1984;71(2):133-9.
7
Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.甲状腺髓样癌。诊断和预后因素的最新进展。
Scand J Clin Lab Invest Suppl. 1991;206:85-92.
8
Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.血清降钙素常规检测后散发性甲状腺髓样癌的外科治疗结果
Eur J Surg Oncol. 2004 Sep;30(7):790-5. doi: 10.1016/j.ejso.2004.05.016.
9
[Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].[降钙素测定作为评估甲状腺髓样癌(C细胞癌)手术结果的一种可能性]
Langenbecks Arch Chir. 1975;Suppl:231-4.
10
Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.降钙素作为一种肿瘤标志物。放射免疫分析法检测降钙素在甲状腺髓样癌患者术后评估中的应用。
N Engl J Med. 1974 May 9;290(19):1035-9. doi: 10.1056/NEJM197405092901901.